Recommendations on dose for managing hypertension suggest starting with carvedilol 12-5 mg daily, with subsequent increases to achieve control of the blood pressure. On the basis of our results, however, a lower starting dose may be needed in elderly hypertensive patients to avoid first dose postural symptoms. Similar caution is probably necessary in other groups of patients likely to be sensitive to combined x , blockade-namely, those taking diuretic drugs or in heart failure. This study was supported by Boehringer Mannheim GMBH, Germany. Women completed questionnaires after a consultation with either a midwife or an obstetrician; during the consultation routine antenatal screening tests, including serum screening for Down's syndrome, were offered. Their knowledge was assessed by using a multiple choice questionnaire with nine items. The internal reliability of the questionnaire was measured by using Cronbach's (x, which gave a coefficient of0 66. The amount of variance in knowledge predicted by demographic variables was assessed by performing discriminant function analyses for each item of the questionnaire. The demographic variables were age, number of children, socioeconomic class, and ethnicity. The table shows the proportions of women giving correct responses to the nine items and the variance predicted by the demographic variables.
1 Louis WJ, Drummer OH, Howes LG, McNeill JJ. Dose-response relationships of antihypertensive drugs during pharmacokinetic and pharmacodynamic studies and their clinical significance. In: Kuhlmann J, Wingender W, Zuckschwerdt W, eds. Dose-response relationship of drugs. Munich: Springer Verlag, 1990:67-9. 2 Louis WJ, McNeill JJ, Workman BS, Drummer OH, Conway EL. A pharmacokinetic study of carvedilol (BM 14.190) 
Comment
Though women in this sample were knowledgeable about practical aspects of undergoing the test, they were less well informed about aspects of the test that could inform their decisions about whether to undergo testing and prepare them for possible adverse outcomes such as being recalled with a high risk result or giving birth to an affected child after a result indicating low risk.
The demographic variables were weak predictors of the variance in knowledge, particuarly items on which fewer than half the women gave the correct answer. The pattem of women's knowledge reflects the observed emphasis of midwives and obstetricians when routinely informing women about prenatal screening': information about the practical aspects of the test is emphasised, whereas information about the likelihood and implications ofpossible results is rarely given.
These results highlight the extent to which prenatal screening programmes are falling short of the counselling standards that have been set.' In addition to the setting of guidelines, effective staff training is needed to teach health professionals how to present prenatal screening tests in ways that will lead to informed decision making by patients.4 
